Overview

Second Uterine Evacuation for Low-risk Gestational Trophoblastic Neoplasia

Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of second uterine curettage in patients with low-risk non-metastatic GTN.
Phase:
Phase 3
Details
Lead Sponsor:
Brigham and Women's Hospital
Collaborator:
Maternidade Escola da Universidade Federal do Rio de Janeiro